These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis. Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123 [TBL] [Abstract][Full Text] [Related]
12. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER Front Immunol; 2022; 13():1070379. PubMed ID: 36591311 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; ; Pardo CA J Neurol Sci; 2021 Aug; 427():117517. PubMed ID: 34090021 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against SARS-CoV-2. Iacono S; Piccoli T; Aridon P; Schirò G; Blandino V; Tarantino D; Agnello L; Ciaccio M; Ragonese P; Salemi G Ann Clin Transl Neurol; 2023 Jun; 10(6):1025-1034. PubMed ID: 37139906 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis. Rajda C; Galla Z; Polyák H; Maróti Z; Babarczy K; Pukoli D; Vécsei L Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290514 [TBL] [Abstract][Full Text] [Related]
16. Spectrum of hospitalized NeuroCOVID diagnoses from a tertiary care neurology centre in Eastern India. Bhansali S; Bagrodia V; Choudhury S; Rahman S; Golder M; Tiwari M; Kumar H J Clin Neurosci; 2021 Nov; 93():96-102. PubMed ID: 34656269 [TBL] [Abstract][Full Text] [Related]
17. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis. Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980 [TBL] [Abstract][Full Text] [Related]
18. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients. Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients. Lersy F; Benotmane I; Helms J; Collange O; Schenck M; Brisset JC; Chammas A; Willaume T; Lefebvre N; Solis M; Hansmann Y; Fabacher T; Caillard S; Mertes PM; Pottecher J; Schneider F; Meziani F; Fafi-Kremer S; Kremer S J Infect Dis; 2021 Feb; 223(4):600-609. PubMed ID: 33249438 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19. Ngo B; Lapp SA; Siegel B; Patel V; Hussaini L; Bora S; Philbrook B; Weinschenk K; Wright L; Anderson EJ; Rostad CA; Gombolay GY Mult Scler Relat Disord; 2021 Oct; 55():103169. PubMed ID: 34333272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]